Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Healthcare Operational Analytics Market

  • MAR2979348
  • 180 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Healthcare and analytics are considered as a lethal combo for success as the use of analytics to reduce down the cost of processes, identify potential test subjects, manage outliers has completely changed the way in which industry thinks and works. It has also enabled huge data organizations to improve quality at low cost which forms an essential part of implementing effective value-based care (VBC) programs. Analytics helps an organization through the systematic use of technologies, methods and data to derive insights and to enable fact-based decision-making for planning, management, operational activities, measurement and learning. With the availability of large datasets in the industry, it has become necessary for the companies to be equipped with tools to use a huge load of data efficiently. Furthermore, analytics also provides a scope to improve other organizational goals such as enhancing customer experience, taking up growth initiatives and identifying failures in the process, thereby, improving overall operational efficiency. Thus, analytics is considered as the next big thing because of its capability to transform operations in healthcare.

Market Dynamics

One of the primary drivers for the healthcare operational analytics market is to enable value-based care (VBC) which is currently drawing enormous investments for the market. Another significant driver of the market is the need to analyze the rapid increase in the sum of data generated by electronic health records (EHRs), claims, medical devices and patients. This data can help to detect hidden patterns, enable self-learning systems and therefore deliver actionable insights to improve operational efficiency. Factors such as an increase in healthcare IT adoption and centralized healthcare are also going to impact the growth of the market positively. The rising awareness about healthcare standards and improving technologies together create a need for imparting excellent experience and service to the customers, thereby, driving the use of operational analytics to enhance the process accordingly.

Another critical factor influencing the growth of the market is the demand for personalized medicine which is strongly correlated with the patient data and therefore requires the application of analytics. However, certain factors like lack of skilled labors, data securing and patient data privacy may hamper the growth of the market. Another critical factor influencing the growth of the market is the demand for personalized medicine which is strongly correlated with the patient data.

Market Segmentation

Global healthcare operational analytics is a sub-segment of healthcare analytics along with clinical data analytics and financial analytics. Healthcare operational analytics can be further segmented by end-user, region and type. By type, the market is segmented into Supply Chain Analytics, Human Resource Analytics and Strategic Analytics. Segmentation by end-user is done into Healthcare, Biotechnology, Pharmaceuticals, Academics and Others. By region, segmentation involves North America, Europe, Asia Pacific, the Middle East and Africa, and Rest of the World.

Geographical analysis

Currently, North America is the leader regarding Market Share and highest CAGR driven by U.S. centralized healthcare mandates and PPACA. Europe takes the second position, growing at relatively low pace. APAC is relatively new to healthcare analytics while the Middle East is found to be an emerging lead in the market.

Key Players

Cerner Corporation, McKesson Corporation, Epic, IBM Corporation, Optum, Oracle, Allscripts, Mede Analytics and Truven Analytics are the major players in the healthcare operational analytics market.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390